Luis Calderón José, López Eric, Cañedo Sergio, Arista-Nasr Julián
Departamentos de Gastroenterología y Patología, Instituto Nacional de la Nutrición y Ciencias Médicas Salvador Zubirán, México, D.F.
Rev Gastroenterol Mex. 2002 Jan-Mar;67(1):17-21.
To analyze pathologic and clinical features in patients with primary gastric lymphoma (PGL) in a reference hospital in Mexico City, and to evaluate the variety of treatments chosen.
Patients with primary gastric lymphoma between 1975 and 2000. Those with histological diagnosis of primary gastric lymphoma confirmed by endoscopic biopsy or gastrectomies were eligible for inclusion in the study. The study was retrolective.
Forty-two patients (21 M, and 21 F) with an average age of 57 years (between 20 and 80 years). The major clinical findings were no weight loss in 31 patients (73%), abdominal pain in 24 patients (57%), gastrointestinal pair in 19 patients (45%), and early satiety in 15 patients (36%). The endoscopic findings were gastric folds in 21 (50%), thickening of gastrics folds in 13 (31%) and tumor in eight patients (19%). We found H pylori in 14 of 16 endoscopic biopsies (87%). High grade lymphomas were found in 29 patients (69%) and low grade lymphoma in 13 (31%). The clinical stage according to the Staging Classification from the Fifth International Conference on Malignant Lymphoma (1993) was 15 patients in stage I (36%), 14 patients in stage II1 (33%). Five patients in stage IV (12%), six patients in stage IIE (14) and one patient in stages II and II2 (2%). The treatment chosen before 1990 was surgery with or without chemotherapy no matter the grade of malignancy, in contrast with the later decade in which solely eradication of H pylori was successfully to cure the disease. In high grade lymphomas, treatment was surgery and chemotherapy for reviewing the study, most patients were alive and without disease.
In the study, most lymphomas were localized in the stomach of perigastric lymph nodes. The most frequent clinical stages were stages I and II1 (36 and 33%, respectively), and their response was successful to all treatments even though most patients were high graded and treated differently.
分析墨西哥城一家参考医院原发性胃淋巴瘤(PGL)患者的病理和临床特征,并评估所选择的各种治疗方法。
研究对象为1975年至2000年间的原发性胃淋巴瘤患者。经内镜活检或胃切除术确诊为原发性胃淋巴瘤的患者符合纳入本研究的条件。本研究为回顾性研究。
42例患者(男21例,女21例),平均年龄57岁(20至80岁)。主要临床症状为:31例患者(73%)无体重减轻,24例患者(57%)有腹痛,19例患者(45%)有胃肠道不适,15例患者(36%)有早饱感。内镜检查结果为:21例(50%)胃黏膜皱襞改变,13例(31%)胃黏膜皱襞增厚,8例患者(19%)有肿瘤。在16例内镜活检中,14例(87%)检测到幽门螺杆菌。29例患者(69%)为高级别淋巴瘤,13例(31%)为低级别淋巴瘤。根据第五届国际恶性淋巴瘤会议(1993年)的分期标准,临床分期为:I期15例(36%),II1期14例(33%),IV期5例(12%),IIE期6例(14%),II和II2期1例(2%)。1990年前,无论恶性程度如何,所选择的治疗方法均为手术加或不加化疗,而在随后的十年中,单纯根除幽门螺杆菌成功治愈了该病。在高级别淋巴瘤中,治疗方法为手术和化疗,经复查,大多数患者存活且无疾病。
在本研究中,大多数淋巴瘤局限于胃或胃周淋巴结。最常见的临床分期为I期和II1期(分别为36%和33%),尽管大多数患者为高级别且治疗方法不同,但所有治疗方法均取得了成功。